Faculty of 1000 evaluation for Phase IA/II, multicentre, open-label study of the CD40 antagonistic monoclonal antibody Lucatumumab in adult patients with advanced non-Hodgkin or Hodgkin lymphoma.

F1000 - Post-publication peer review of the biomedical literature ◽

10.3410/f.718174994.793487135 ◽

2013 ◽

Author(s):

Nicolas Mounier

Keyword(s):

Monoclonal Antibody ◽

Hodgkin Lymphoma ◽

Adult Patients ◽

Open Label Study ◽

Download Full-text

Phase IA/II, multicentre, open-label study of the CD40 antagonistic monoclonal antibody lucatumumab in adult patients with advanced non-Hodgkin or Hodgkin lymphoma

British Journal of Haematology ◽

10.1111/bjh.12630 ◽

2013 ◽

Vol 164 (2) ◽

pp. 258-265 ◽

Author(s):

Michelle Fanale ◽

Sarit Assouline ◽

John Kuruvilla ◽

Philippe Solal-Céligny ◽

Dae S. Heo ◽

...

Keyword(s):

Monoclonal Antibody ◽

Hodgkin Lymphoma ◽

Adult Patients ◽

Open Label Study ◽

Download Full-text

A Phase I, Open-Label Study of Siltuximab, an Anti–IL-6 Monoclonal Antibody, in Patients with B-cell Non-Hodgkin Lymphoma, Multiple Myeloma, or Castleman Disease

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-12-3349 ◽

2013 ◽

Vol 19 (13) ◽

pp. 3659-3670 ◽

Author(s):

Razelle Kurzrock ◽

Peter M. Voorhees ◽

Corey Casper ◽

Richard R. Furman ◽

Luis Fayad ◽

...

Keyword(s):

Multiple Myeloma ◽

Monoclonal Antibody ◽

Phase I ◽

B Cell ◽

Hodgkin Lymphoma ◽

Castleman Disease ◽

Open Label Study ◽

Label Study ◽

Non Hodgkin Lymphoma

Download Full-text

Preliminary findings from a phase I, multicenter, open-label study of the anti-CD37 antibody-drug conjugate (ADC), IMGN529, in adult patients with relapsed or refractory non-Hodgkin lymphoma (NHL).

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.8526 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. 8526-8526 ◽

Author(s):

Anastasios Stathis ◽

Kami J. Maddocks ◽

Ian Flinn ◽

Alex Mejia ◽

Maria Lia Palomba ◽

...

Keyword(s):

Phase I ◽

Hodgkin Lymphoma ◽

Adult Patients ◽

Antibody Drug Conjugate ◽

Open Label Study ◽

Label Study ◽

Drug Conjugate ◽

Non Hodgkin Lymphoma ◽

Download Full-text

PB2008 AN OPEN-LABEL STUDY OF BENDAMUSTINE HYDROCHLORIDE IN CHINESE PATIENTS WITH INDOLENT NON-HODGKIN LYMPHOMA (NHL) REFRACTORY TO RITUXIMAB TREATMENT

10.1097/01.hs9.0000566524.82977.2b ◽

2019 ◽

Vol 3 (S1) ◽

pp. 908

Author(s):

Y. Shi ◽

X. Hong ◽

H. Huang ◽

W. Xu ◽

X. Han ◽

...

Keyword(s):

Hodgkin Lymphoma ◽

Chinese Patients ◽

Open Label Study ◽

Label Study ◽

Non Hodgkin Lymphoma

Download Full-text

A phase 1b multicenter, open-label study of investigational TAK-228 (MLN0128) plus TAK-117 (MLN1117) in adult patients with advanced nonhematologic malignancies

European Journal of Cancer ◽

10.1016/s0959-8049(16)32625-9 ◽

2016 ◽

Vol 69 ◽

pp. S11-S12 ◽

Author(s):

D. Juric ◽

J. Lopez ◽

D. Rasco ◽

T. Macarulla Mercadé ◽

Q. Xu ◽

...

Keyword(s):

Adult Patients ◽

Open Label Study ◽

Label Study ◽

Download Full-text

Guselkumab, a human interleukin-23 monoclonal antibody in Japanese patients with generalized pustular psoriasis and erythrodermic psoriasis: Efficacy and safety analyses of a 52-week, phase 3, multicenter, open-label study

The Journal of Dermatology ◽

10.1111/1346-8138.14294 ◽

2018 ◽

Vol 45 (5) ◽

pp. 529-539 ◽

Author(s):

Shigetoshi Sano ◽

Hiroshi Kubo ◽

Hitomi Morishima ◽

Ryosuke Goto ◽

Richuan Zheng ◽

...

Keyword(s):

Monoclonal Antibody ◽

Japanese Patients ◽

Efficacy And Safety ◽

Phase 3 ◽

Open Label Study ◽

Label Study ◽

Generalized Pustular Psoriasis ◽

Erythrodermic Psoriasis ◽

Download Full-text

Phase II multicenter open label study of pembrolizumab and entinostat in adult patients with metastatic uveal melanoma (PEMDAC study)

Annals of Oncology ◽

10.1093/annonc/mdz394.068 ◽

2019 ◽

Vol 30 ◽

pp. v907 ◽

Author(s):

H. Jespersen ◽

R. Olofsson Bagge ◽

G. Ullenhag ◽

A. Carneiro ◽

H. Helgadottir ◽

...

Keyword(s):

Uveal Melanoma ◽

Phase Ii ◽

Adult Patients ◽

Open Label Study ◽

Download Full-text

A phase II, randomized, open-label study evaluating the antitumor activity of MEDI-522, a humanized monoclonal antibody directed against the human alpha v beta 3 (avb3) integrin, ± dacarbazine (DTIC) in patients with metastatic melanoma (MM)

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.7507 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 7507-7507 ◽

Author(s):

P. Hersey ◽

J. Sosman ◽

S. O’Day ◽

J. Richards ◽

A. Bedikian ◽

...

Keyword(s):

Monoclonal Antibody ◽

Antitumor Activity ◽

Metastatic Melanoma ◽

Phase Ii ◽

Open Label Study ◽

Label Study ◽

Humanized Monoclonal Antibody ◽

Download Full-text

Changes in anxiety symptoms of ADHD adult patients with co-morbid refractory generalized anxiety disorder treated with mixed amphetamine salts (ADDERALL XR): An open label study

Journal of Affective Disorders ◽

10.1016/j.jad.2010.02.070 ◽

2010 ◽

Vol 122 ◽

pp. S58

Author(s):

A. Gabriel

Keyword(s):

Anxiety Disorder ◽

Generalized Anxiety Disorder ◽

Anxiety Symptoms ◽

Adult Patients ◽

Generalized Anxiety ◽

Open Label Study ◽

Download Full-text

A 52-week, open-label study of the efficacy and safety of ixekizumab, an anti-interleukin-17A monoclonal antibody, in patients with chronic plaque psoriasis

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2014.07.048 ◽

2014 ◽

Vol 71 (6) ◽

pp. 1176-1182 ◽

Author(s):

Kenneth B. Gordon ◽

Craig L. Leonardi ◽

Mark Lebwohl ◽

Andrew Blauvelt ◽

Gregory S. Cameron ◽

...

Keyword(s):

Monoclonal Antibody ◽

Plaque Psoriasis ◽

Efficacy And Safety ◽

Chronic Plaque Psoriasis ◽

Open Label Study ◽

Label Study ◽

Interleukin 17A

Download Full-text